Get In Touch
541 Melville Ave, Palo Alto, CA 94301,
ask@ohio.clbthemes.com
Ph: +1.831.705.5448
Work Inquiries
work@ohio.clbthemes.com
Ph: +1.831.306.6725

AI powered early diagnostics for neurodegenerative diseases

some facts

Every 3 seconds 1 person develops
dementia in the world.

No cure
There is no cure yet.
1.4T EUR
Health expense in high income countries on dementia by 2050.
25%
Faulty diagnosis. 50% gets no diagnose at all.
131.5M
People with dementia by 2030
10M
People with Parkinson’s Disease

We practice deep medicine

Or how Artificial Intelligence can help
tackle neurodegeneration.

In conjunction with increasingly advanced computational approaches, a wide spectrum of neurodegenerative disease models, data-driven or knowledge-driven, have been developed. We want to capture biomedical data to detect neurodegenerative diseases (like Alzheimer’s, Parkinson’s disease) 15-20 years before the symptoms show. AI powered diagnostics and therapies to offer a longer health span.

Neurodegenerative diseases

Neurodegeneration is the progressive loss of structure and/or function of neurons, including death of neurons.
Such diseases are incurable. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances.

Alzheimer’s Disease

Parkinson’s Disease

Multiple Sclerosis

Other neurodegenerative diseases

We practice deep medicine. Solving
healthcare issues with artificial intelligence.

We introduce early non-invasive diagnostics of neurodegenerative
diseases among adults aged 45 and up by affordable and an AI powered
mobile application using digital biomarkers.

01

Noninvasive technology cuts costs & allows for broader diagnostics

02

Innovative high quality data capturing allows for early detection

03

Digital biomarkers predict disease development where invasive methods fail

04

AI-powered solution that improves with every additional test

OUR TECHNOLOGY

Intellectual Property

High Quality Data Capture Solution

The core technology of
Deep Diagnostics.

Neuro digital Biomarkers & AI Algorithms

The core technology of Deep Diagnostics.

Micro & Macro facial expression detection

Measuring the quality of life and well-being of people with dementia or other neurodegenerative diseases.

Contact us to Learn More
About our Process

Neurodegeneration is the progressive loss of structure and/or
function of neurons, including death of neurons. 

OUR TARGET SEGMENT

All people 45 years and up

We target healthy people of 45 years and older; people that have
early signs of dementia; or have been diagnosed with a neurodegenerative disease.

People that want to maintain
a healthy lifestyle

People with early signs of
dementia

diagnosed with a neurodegenerative disease

PROGRESS

Our Journey

A team of over 10 data & medical scientists have researched & developed
this solution over the last 3 years. We expect to release both solutions
by Q1 2023 into the market.

2018

Start of research & development on Deep Diagnose

2019

First release test version of Deep Diagnose application

2020-21

Deep Diagnose CE certification

2022

Release to market

Services

We provide a diagnostics
& therapy solution.

features

features

Our Products

We target healthy people of 45 years and older; people that have
early signs of dementia; or have been diagnosed with a neurodegenerative disease.

Deep Diagnose

We researched the available neurocognitive tests and pre-selected the methods that could provide us with additional input (digital biomarkers based on eye-tracking, micro-expressions, hand-eye coordination, and natural speech) about the neurocognitive health of the test taker.

The tasks we selected are scored and the user’s reaction times (time to respond to the tasks) are recorded in order to define possible differences amongst healthy and non-healthy individuals.

Deep Therapy

HOW IT WORKS

The Business Model

PHASE 1: Deep Diagnose
PHASE 2: Deep Therapy

About us

Our Growing Team

Dr. Hendrik Schwagten, PhD
Head of Medical Research
Tom De Bast, MSc
Chief Marketing
Officer
James Troch, MSc
Chief Executive
Officer
Annemiek Van Hese, MSc
Chief Executive
Officer
Timothy de Leeuw, BSc
Product Manager
Prof. Dr. Patrick Wessa, PhD
Head of AI Research
Dr. Salza Palpurina, PhD
Head Data Science
Dr. Iordan Hristov, PhD
Head Data Science
drs. Ivan Arshinkov, MSc
Head Data Science
Research & Development team
Head of Medical Research
Advisory board
Hospitals and Specialists

GET IN TOUCH

AI powered early diagnostics for neurodegenerative diseases

Deep Medicine

Email

hello@deepmedicine.io
deepmedicine.io